logo
Say goodbye to JetBlue partnership with key airline; benefits end soon

Say goodbye to JetBlue partnership with key airline; benefits end soon

Yahoo4 days ago
A partnership between JetBlue and Hawaiian Airlines is coming to an end.
JetBlue made the announcement on Sunday, June 29.
'We wanted to let you know that our loyalty partnership with Hawaiian Airlines will be coming to an end,' the announcement reads.
The last day customers can book Hawaiian Airlines flights to earn or redeem TrueBlue points will be Sept. 30 of this year. Travel must be completed by Mar. 31, 2026.
TrueBlue points are used to get cheaper or free flights on JetBlue or other bonuses. Full rewards information can be found here.
The deadline to submit any retroactive requests to earn TrueBlue points on Hawaiian is also on March 31, 2026, according to the statement.
'We apologize for any convenience,' JetBlue said.
JetBlue and Hawaiian began their partnership in 2012, which allowed passengers to book connecting itineraries between JetBlue's domestic network and Hawaiian's transpacific and inter-island flights, according to Airline Geeks.
The news comes after Hawaiian airlines announced its plans to integrate with Alaska Airlines.
The latest from MassLive
Bruins sign forward prospect to two-way contract after AHL season ended due to injury
Springfield police arrest suspect, confiscate high-capacity gun, magazines after shooting
9 indicted in Boston in connection with $5M raised for North Korean weapons
Red Sox lineup: Rookie batting 7th in return from leave; David Hamilton at 2B
'Sore winner': Trump drops lawsuit against pollster who predicted he'd lose Iowa
Read the original article on MassLive.
Solve the daily Crossword
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

NeuroScientific Biopharmaceuticals (ASX:NSB) jumps 14% this week, though earnings growth is still tracking behind one-year shareholder returns
NeuroScientific Biopharmaceuticals (ASX:NSB) jumps 14% this week, though earnings growth is still tracking behind one-year shareholder returns

Yahoo

time6 minutes ago

  • Yahoo

NeuroScientific Biopharmaceuticals (ASX:NSB) jumps 14% this week, though earnings growth is still tracking behind one-year shareholder returns

While some are satisfied with an index fund, active investors aim to find truly magnificent investments on the stock market. When you buy and hold the right company, the returns can make a huge difference to both you and your family. For example, the NeuroScientific Biopharmaceuticals Limited (ASX:NSB) share price is up a whopping 576% in the last 1 year, a handsome return in a single year. Also pleasing for shareholders was the 410% gain in the last three months. The longer term returns have not been as good, with the stock price only 6.4% higher than it was three years ago. We love happy stories like this one. The company should be really proud of that performance! On the back of a solid 7-day performance, let's check what role the company's fundamentals have played in driving long term shareholder returns. Trump has pledged to "unleash" American oil and gas and these 15 US stocks have developments that are poised to benefit. There is no denying that markets are sometimes efficient, but prices do not always reflect underlying business performance. One flawed but reasonable way to assess how sentiment around a company has changed is to compare the earnings per share (EPS) with the share price. During the last year NeuroScientific Biopharmaceuticals grew its earnings per share (EPS) by 54%. The share price gain of 576% certainly outpaced the EPS growth. So it's fair to assume the market has a higher opinion of the business than it a year ago. The fairly generous P/E ratio of 70.06 also points to this optimism. The graphic below depicts how EPS has changed over time (unveil the exact values by clicking on the image). This free interactive report on NeuroScientific Biopharmaceuticals' earnings, revenue and cash flow is a great place to start, if you want to investigate the stock further. A Different Perspective We're pleased to report that NeuroScientific Biopharmaceuticals shareholders have received a total shareholder return of 576% over one year. That's better than the annualised return of 1.2% over half a decade, implying that the company is doing better recently. Given the share price momentum remains strong, it might be worth taking a closer look at the stock, lest you miss an opportunity. I find it very interesting to look at share price over the long term as a proxy for business performance. But to truly gain insight, we need to consider other information, too. To that end, you should learn about the 4 warning signs we've spotted with NeuroScientific Biopharmaceuticals (including 2 which are potentially serious) . For those who like to find winning investments this free list of undervalued companies with recent insider purchasing, could be just the ticket. Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on Australian exchanges. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Trump: Aug. 1 tariff deadline ‘stands strong'
Trump: Aug. 1 tariff deadline ‘stands strong'

Yahoo

time34 minutes ago

  • Yahoo

Trump: Aug. 1 tariff deadline ‘stands strong'

President Trump on Wednesday indicated there would be no extensions of the deadline at the end of the week, when steep tariffs are set to go into effect on many nations. 'The August first deadline is the August first deadline — It stands strong, and will not be extended. A big day for America!!!' Trump posted on Truth Social. Trump has issued letters to more than a dozen countries informing them of tariff rates they will face to export their goods into the United States beginning Aug. 1. Those include a 25 percent tariff on India, a 35 percent tariff on Bangladesh and a 50 percent tariff on Brazil, among others. The White House has struck deals with a handful of other countries to set lower tariff rates, including with Japan, the European Union, Indonesia and the United Kingdom. Critics have argued the details around those agreements are still scarce and have noted that the tariff rate those countries will pay, while lower than an initial threat, is still higher than it was before Trump took office. The timing and severity of tariffs on other nations have been shifting targets since Trump took office, after he vowed on the campaign trail to aggressively impose duties on imports. He has repeatedly threatened tariffs on other nations, only to back off or delay their imposition. The president on April 2 announced 'reciprocal' tariffs on dozens of other countries, using trade deficits to help calculate the tariff rate. But a week later, he lowered those rates to 10 percent for 90 days as markets reacted negatively, giving time for negotiations. The 90-day window was set to expire in early July, only for Trump to set a new deadline of Aug. 1. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed. Solve the daily Crossword

Trump says he's not ‘seeking' summit with Xi
Trump says he's not ‘seeking' summit with Xi

Yahoo

time34 minutes ago

  • Yahoo

Trump says he's not ‘seeking' summit with Xi

President Trump said that he is not looking for a summit with Chinese President Xi Jinping, pushing back on reporting that the tariff talks this week could set the groundwork for a meeting with his counterpart. 'The Fake News is reporting that I am SEEKING a 'Summit' with President Xi of China. This is not correct, I am not SEEKING anything!' Trump said on Truth Social. 'I may go to China, but it would only be at the invitation of President Xi, which has been extended. Otherwise, no interest! Thank you for your attention to this matter.' Talks between the U.S. and China are going on in Stockholm this week with Treasury Secretary Scott Bessent and his counterparts, which marks the third round of talks between the two nations. The meeting could set up an extended tariff truce, which could lead to a meeting with Trump and Xi later this year, NBC News reported. China and the U.S. are facing an Aug. 12 deadline following agreements announced in May and June that brought down mutually imposed triple-digit tariffs. For other trading partners, Trump has set an Aug. 1 deadline for the resumption of tariffs. 'We have a good relationship with China,' Trump said Monday. 'China's tough.' The president last month said Xi was 'extremely hard to make a deal' with and the two leaders have had a fraught relationship in recent years. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed. Solve the daily Crossword

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store